Cargando…
A pilot study of volumetric and density tumor analysis of ACC patients treated with vorinostat in a phase II clinical trial()
RATIONALE AND OBJECTIVES: Adenoid cystic carcinoma (ACC) is a rare salivary gland cancer. The vast majority of clinical trials evaluating systemic therapy efficacy in solid tumors use the Response Evaluation Criteria in Solid Tumors (RECIST) to measure response that is limited to 2 dimensional only...
Autores principales: | Malarkey, Molly, Toscano, Alex P., Bagheri, Mohammad Hadi, Solomon, Jeffrey, Machado, Laura B., LoRusso, Patricia, Chen, Alice, Folio, Les R., Goncalves, Priscila H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428039/ https://www.ncbi.nlm.nih.gov/pubmed/37593628 http://dx.doi.org/10.1016/j.heliyon.2023.e18680 |
Ejemplares similares
-
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
por: Goncalves, Priscila H., et al.
Publicado: (2017) -
Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015) -
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020) -
Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009) -
Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST
por: Fenerty, Kathleen E., et al.
Publicado: (2016)